Результати пошуку - Jacob Devine
- Показ 1 - 3 результатів із 3
-
1
Physical Function, Pain Severity, and Fatigue in Patients with Relapsed/Refractory Multiple Myeloma: Health-Related Quality of Life Results in Patients Receiving Venetoclax or Plac... за авторством Cristina Gasparetto, Rakesh Popat, Shaji Kumar, Michèle Cavo, Javier de la Rubia, Vânia Hungria, Hans Salwender, Kenshi Suzuki, Inho Kim, James Farley Rafael Maciel, Liang‐Tsai Hsiao, Philippe Moreau, Simon J. Harrison, Jia Jia, Sudeep Karve, Esprit Ma, Jacob Devine, Katy Benjamin
Опубліковано 2019Artigo -
2
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia за авторством Keith W. Pratz, Panayiotis Panayiotidis, Christian Récher, Xudong Wei, Brian A. Jonas, Pau Montesinos, Vladimir Ivanov, Andre C. Schuh, Courtney D. DiNardo, Jan Novák, Vlatko Pejša, Don A. Stevens, Su‐Peng Yeh, Inho Kim, Mehmet Turgut, Nicola Fracchiolla, Kazuhito Yamamoto, Yishai Ofran, Andrew H. Wei, Cat N. Bui, Katy Benjamin, Rajesh Kamalakar, Jalaja Potluri, Wellington Mendes, Jacob Devine, Walter Fiedler
Опубліковано 2022Artigo -
3
Venetoclax-Obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the phase 3 CLL14 study за авторством Othman Al‐Sawaf, Sandra Robrecht, Can Zhang, Stefano Olivieri, Yi Meng Chang, Anna-Maria Fink, Eugen Tausch, Christof Schneider, Matthias Ritgen, Karl‐Anton Kreuzer, Liliya Sivcheva, Carsten Utoft Niemann, Anthony P. Schwarer, Javier Loscertales, Robert Weinkove, Dirk Strumberg, Allanah Kilfoyle, Beenish S. Manzoor, Dureshahwar Jawaid, Nnadozie Emechebe, Jacob Devine, Michelle Boyer, Eva Diana Runkel, Barbara Eichhorst, Stephan Stilgenbauer, Yanwen Jiang, Michael Hallek, Kirsten Fischer
Опубліковано 2024Artigo
Інструменти для пошуку:
Пов'язані теми
Internal medicine
Medicine
Oncology
Alternative medicine
Chemotherapy
Chronic lymphocytic leukemia
Leukemia
Nursing
Pathology
Placebo
Quality of life (healthcare)
Venetoclax
Bortezomib
Chlorambucil
Clinical endpoint
Clinical trial
Computer science
Computer security
Cyclophosphamide
Cytarabine
Dexamethasone
Environmental health
Gastroenterology
IGHV@
Multiple myeloma
Myeloid leukemia
Obinutuzumab
Physical therapy
Population
Salvage therapy